Endothelin-converting enzyme-1 in cancer aggressiveness
Authors:
Open Access
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 452, 152-157
Abstract
No abstract availableKeywords
Funding Information
- FONDECYT (1160889)
This publication has 67 references indexed in Scilit:
- Endosomal proteolysis regulates calcitonin gene‐related peptide responses in mesenteric arteriesBritish Journal of Pharmacology, 2012
- Endothelin-Converting Enzyme-1 Actions Determine Differential Trafficking and Signaling of Corticotropin-Releasing Factor Receptor 1 at High Agonist ConcentrationsMolecular Endocrinology, 2012
- Neurotensin-induced Proinflammatory Signaling in Human Colonocytes Is Regulated by β-Arrestins and Endothelin-converting Enzyme-1-dependent Endocytosis and Resensitization of Neurotensin Receptor 1Journal of Biological Chemistry, 2012
- Endothelin‐converting enzyme‐1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neuronesThe Journal of Physiology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- EndothelinCellular and Molecular Life Sciences, 2010
- Caveolin-1–mediated Suppression of Cyclooxygenase-2 via a β-catenin-Tcf/Lef–dependent Transcriptional Mechanism Reduced Prostaglandin E2 Production and Survivin ExpressionMolecular Biology of the Cell, 2009
- Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasionBritish Journal of Cancer, 2008
- Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin–T cell factor/lymphoid enhancer binding factor-dependent transcriptionProceedings of the National Academy of Sciences, 2006
- Protein Kinase C Regulates the Cell Surface Activity of Endothelin-Converting Enzyme-1International Journal of Peptide Research and Therapeutics, 2006